Advertisement

Topics

BlueRock Therapeutics Adds Min Wang to C-Suite

16:40 EST 28 Nov 2018 | Xconomy

Min Wang has been appointed chief legal and administrative officer of Cambridge, MA-based BlueRock Therapeutics. Wang was most recently general counsel and corporate secretary of Agios Pharmaceuticals (NASDAQ: AGIO). Her experience also includes posts at Genentech and Merck (NYSE: MRK). BlueRock, which develops regenerative medicines for tough-to-treat diseases, launched in late 2016 backed by $225 […]

Original Article: BlueRock Therapeutics Adds Min Wang to C-Suite

NEXT ARTICLE

More From BioPortfolio on "BlueRock Therapeutics Adds Min Wang to C-Suite"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...